Skip to content

Effect and Essentiality of Vertebroplasty Surgery in Acute Vertebral Compression Fractures

Effect and Essentiality of Vertebroplasty Surgery in Acute Vertebral Compression Fractures: a Multiple Center Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03360383
Enrollment
400
Registered
2017-12-04
Start date
2018-02-01
Completion date
2020-06-01
Last updated
2017-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Fractures

Keywords

Spinal Fractures/surgery, Vertebroplasty, Quality-Adjusted Life Years

Brief summary

Percutaneous vertebroplasty is now a common procedures of patients with acute osteoporotic vertebral compression fractures in medical units all over China, but the efficacy and essentiality of the surgery remain uncertain and is the subject of this study. This is a multiple center open-label randomised trial. Patients were randomly allocated to percutaneous vertebroplasty or conservative treatment. Because of the procedure , neither patients nor investigators were blinded. The primary outcome was pain relief at 1 month and 1 year.

Detailed description

This study will use a randomised controlled trial to access the efficacy and essentiality of the surgery for vertebral compression fractures. Patients aged 50 years or older, had vertebral compression fractures on spine radiograph (minimum 15% height loss) will be invited to take part. Patients will be randomised into 2 arms with average amount. The participants in the intervention arm will have percutaneous vertebroplasty ; those randomised to the control arm will receive current standard conservative treatment methods. Patients were clinically assessed at baseline (the day of surgery or treatment), and at 1 day, 1 week, 1 month, 3 months, 6 months, and 1 year afterwards. The primary outcome will be the pain release , categorised according to WHO classification.

Interventions

Undertake Percutaneous vertebroplasty with polymethylmetacrylate bone cement.

PROCEDUREconservative treatment

complete on bed with prevention of complications

Sponsors

Peking University People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* vertebral compression fracture on spine radiograph (minimum 15% height loss) * level of fracture at Th5 or lower; back pain for 6 weeks or less * focal tenderness at fracture level on physical examination * bone oedema of vertebral fracture on MRI * decreased bone density (T scores ≤-1)

Exclusion criteria

* severe cardiopulmonary comorbidity * suspected underlying malignant disease * radicular syndrome * spinal-cord compression syndrome * contraindication for radiography exam

Design outcomes

Primary

MeasureTime frameDescription
change of pain relief1 day, 1 week, 1 month, 3 months, 6 months, and 1 yearWorld Health Organization pain classification

Secondary

MeasureTime frameDescription
quality of life1 day, 1 week, 1 month, 3 months, 6 months, and 1 yearQuality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO)

Contacts

Primary Contactchen guo
fantasy_g@163.com8618055644700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026